124 related articles for article (PubMed ID: 9792145)
1. In vitro effect of amifostine on haematopoietic progenitors exposed to carboplatin and non-alkylating antineoplastic drugs: haematoprotection acts as a drug-specific progenitor rescue.
Pierelli L; Scambia G; Fattorossi A; Bonanno G; Battaglia A; Perillo A; Menichella G; Panici PB; Leone G; Mancuso S
Br J Cancer; 1998 Oct; 78(8):1024-9. PubMed ID: 9792145
[TBL] [Abstract][Full Text] [Related]
2. Amifostine protects primitive hematopoietic progenitors against chemotherapy cytotoxicity.
List AF; Heaton R; Glinsmann-Gibson B; Capizzi RL
Semin Oncol; 1996 Aug; 23(4 Suppl 8):58-63. PubMed ID: 8783669
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effects toward human hematopoietic progenitor cells and tumor cell lines of paclitaxel, docetaxel, and newly developed analogues IDN5109, IDN5111, and IDN5127.
Ferlini C; Distefano M; Pierelli L; Bonanno G; Riva A; Bombardelli E; Ojima I; Mancuso S; Scambia G
Oncol Res; 1999; 11(10):471-8. PubMed ID: 10850888
[TBL] [Abstract][Full Text] [Related]
4. [Protective effects of amifostine on hematopoietic stem/progenitor cells against chemotherapeutic damage].
Chen BA; Li CP; Zhou M; Gao C; Ding JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):803-6. PubMed ID: 15631665
[TBL] [Abstract][Full Text] [Related]
5. Effects of retinoic acid and amifostine on in vitro growth of normal hemopoietic progenitor cells.
Arboscello E; Botta M; Romero D; Schenone E; Mencoboni M; Bogliolo G; Pannacciulli I
Anticancer Res; 2001; 21(2A):1139-43. PubMed ID: 11396153
[TBL] [Abstract][Full Text] [Related]
6. Effects of docetaxel on the in vitro growth of human myeloid progenitors.
Botta M; Arboscello E; Lerza R; Mencoboni M; Bogliolo G; Pannacciulli I
Anticancer Res; 1999; 19(3A):1855-8. PubMed ID: 10470127
[TBL] [Abstract][Full Text] [Related]
7. Amifostine does not preferentially stimulate the growth of residual polyclonal progenitor cells in myelodysplastic syndromes.
Delforge M; Raets V; Van Duppen V; Boogaerts M
Leuk Res; 2003 Jul; 27(7):593-8. PubMed ID: 12681358
[TBL] [Abstract][Full Text] [Related]
8. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
9. Amifostine (WR-2721) protects normal haematopoietic stem cells against cyclophosphamide derivatives' toxicity without compromising their antileukaemic effects.
Douay L; Hu C; Giarratana MC; Gorin NC
Eur J Cancer; 1995; 31A Suppl 1():S14-6. PubMed ID: 7577094
[TBL] [Abstract][Full Text] [Related]
10. Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained.
Taylor CW; Wang LM; List AF; Fernandes D; Paine-Murrieta GD; Johnson CS; Capizzi RL
Eur J Cancer; 1997 Sep; 33(10):1693-8. PubMed ID: 9389935
[TBL] [Abstract][Full Text] [Related]
11. [Role of amifostine against the effect of etoposide on non-Hodgkin lymphoma bone marrow derived mesenchymal stem cells: an in vitro experiment].
Li QB; Tang XQ; Zhao ZG; Wang HX; You Y; Chen ZC; Zou P
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):812-5. PubMed ID: 17565862
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects.
Sehmi R; Howie K; Sutherland DR; Schragge W; O'Byrne PM; Denburg JA
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):645-55. PubMed ID: 8918371
[TBL] [Abstract][Full Text] [Related]
13. Amifostine stimulates the formation of hematopoietic bone marrow progenitors from B-cell chronic lymphocytic leukemia.
Tsatalas C; Spanoudakis E; Pantelidou D; Margaritis D; Kotsianidis I; Chalkia P; Tripsianis G; Basdiara I; Kartasis Z; Karakolios A; Bourikas G
Acta Haematol; 2004; 112(3):136-40. PubMed ID: 15345895
[TBL] [Abstract][Full Text] [Related]
14. Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients.
Fulda S; Fichtner I; Hero B; Berthold F
Med Pediatr Oncol; 2001 Jan; 36(1):199-202. PubMed ID: 11464883
[TBL] [Abstract][Full Text] [Related]
15. Amifostine and chemotherapy-related thrombocytopenia.
Budd GT
Semin Oncol; 1996 Aug; 23(4 Suppl 8):49-52. PubMed ID: 8783667
[TBL] [Abstract][Full Text] [Related]
16. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the antitumor effect of Merocyanine 540-mediated photodynamic therapy by amifostine and amphotericin B.
Tsujino I; Miyagi K; Sampson RW; Sieber F
Photochem Photobiol; 2006; 82(2):458-65. PubMed ID: 16613499
[TBL] [Abstract][Full Text] [Related]
18. Influence of amifostine on reconstitution of lymphocyte subpopulations after conventional- and high-dose chemotherapy in patients with germ cell tumor.
Rick O; Beyer J; Schwella N; Siegert W
Ann Hematol; 2002 Dec; 81(12):717-22. PubMed ID: 12483368
[TBL] [Abstract][Full Text] [Related]
19. Influence of amifostine on the toxicity and pharmacokinetics of docetaxel in metastatic breast cancer patients: a pilot study.
Freyer G; Hennebert P; Awada A; Gil T; Kerger J; Selleslags J; Brassinne C; Piccart M; de Valeriola D
Clin Cancer Res; 2002 Jan; 8(1):95-102. PubMed ID: 11801544
[TBL] [Abstract][Full Text] [Related]
20. In vitro antagonistic cytotoxic interactions between platinum drugs and taxanes on bone marrow progenitor cell CFU-GM.
de Graaff M; Maliepaard M; Pluim D; Floot BJ; Slaper-Cortenbach IC; Schellens JH
Anticancer Drugs; 1999 Feb; 10(2):213-8. PubMed ID: 10211552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
